Tenderwize
Back to tender search

Open house discount agreements for Rilpivirin depot injection suspension, ATC J05AG05

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 595 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rilpivirin in der Darreichungsform Depot-Injektionssuspension, ATC J05AG05

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or maximum framework amount is provided. It is unclear what volume of business these discou...

The open-house agreements may automatically terminate if a national or regional discount contract for the same product...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Non-exclusive discount agreements for the pharmaceutical product Rilpivirin (ATC J05AG05) in depot injection suspension form.
  • Contracts are offered to all eligible pharmaceutical companies without competition.
Show full summary

This is an open-house model (not a standard procurement procedure) for non-exclusive discount agreements for the pharmaceutical product Rilpivirin in depot injection suspension form (ATC J05AG05). The buyer, AOK Bayern, offers identical, non-negotiable contracts to all interested pharmaceutical companies that meet the eligibility criteria. The early possible start date is 01.06.2026, all contracts end 31.05.2028. Contract conclusion is possible anytime until 03.04.2028. Termination is possible with one month's notice. There is no competition or award selection; any eligible company can join. The estimated value is not provided.

Risks

No estimated contract value or maximum framework amount is provided. It is unclear what volume of business these discou...

The open-house agreements may automatically terminate if a national or regional discount contract for the same product...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contracting partners.
  • Eligibility is proven by a signed self-declaration of reliability (downloadable from the procurement documents).

Administrative

  • Submission must include the signed contract, the signed annex "Determination of the contract medicines", and the signed self-declaration.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreements for Rilpivirin depot injection suspension, ATC J05AG05

Non-exclusive discount agreements for the active substance Rilpivirin in depot injection suspension form. Contracts are identical for all participants. The contract period is from 01.06.2026 to 31.05.2028. Submission deadlines are rolling: to get a contract start on the next month's first day, complete documents must be submitted by the 3rd of the previous month.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 03, 2028

Procurement Details

Publication date
14 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
255478-2026

Documents (2)

Similar tenders